Publications by authors named "Buatois S"

Aims: Crovalimab is a novel C5 inhibitor administered first intravenously and then subcutaneously in patients with paroxysmal nocturnal haemoglobinuria (PNH) naive to complement inhibition or switching from eculizumab or ravulizumab. Crovalimab showed efficacy and safety comparable to eculizumab in the pivotal COMMODORE 2 and supporting studies.

Methods: We characterized crovalimab pharmacokinetics and the relationship between exposure pharmacokinetic parameters and pharmacodynamic biomarkers, efficacy and safety endpoints using pooled data (healthy volunteers [n = 9], naive [n = 210] and switched [n = 211] patients).

View Article and Find Full Text PDF

Objectives: To evaluate the tolerability of crovalimab versus eculizumab in C5 inhibitor (C5i)-naive and -experienced patients with PNH from COMMODORE 2, 3 and 1 (NCT04434092, NCT04654468 and NCT04432584).

Methods: Pooled safety data were assessed in the total crovalimab and eculizumab populations and by C5i-naive versus C5i-switched status in patients receiving crovalimab. Analyses include 6.

View Article and Find Full Text PDF

Population pharmacokinetic (PK) models are widely used to inform drug development by pharmaceutical companies and facilitate drug evaluation by regulatory agencies. Developing a population PK model is a multi-step, challenging, and time-consuming process involving iterative manual model fitting and evaluation. A tool for fully automatic model development (AMD) of common population PK models is presented here.

View Article and Find Full Text PDF
Article Synopsis
  • Crovalimab is a new C5 inhibitor that can be self-administered every four weeks and is being tested in a phase 3 trial against another treatment, eculizumab, for patients with paroxysmal nocturnal hemoglobinuria (PNH).
  • The trial's focus shifted from efficacy to safety due to not meeting recruitment goals, and exploratory endpoints included various measures of patient health and satisfaction.
  • Results showed that while both treatments had adverse events, crovalimab showed sustained effectiveness and 85% of patients preferred it over eculizumab, suggesting it might be a more manageable treatment option for long-term PNH care.
View Article and Find Full Text PDF
Article Synopsis
  • - Crovalimab is a new treatment for paroxysmal nocturnal hemoglobinuria that allows for easy self-administration every four weeks and is shown to be as effective as the existing treatment eculizumab in maintaining hemolysis control and avoiding transfusions.
  • - The COMMODORE 2 trial involved 204 patients and compared the effects of crovalimab with eculizumab over 24 weeks, finding similar outcomes for key health measures, including hemoglobin stabilization and fatigue reduction.
  • - Both treatments were safe, with no cases of meningococcal infections reported, and many patients preferred crovalimab after switching from eculizumab, showcasing its favorable benefit-risk profile.
View Article and Find Full Text PDF

Covariate analysis in population pharmacokinetics is key for adjusting doses for patients. The main objective of this work was to compare the adequacy of various modeling approaches on covariate clinical relevance decision-making. The full model, stepwise covariate model (SCM) and SCM+ PsN algorithms were compared in a clinical trial simulation of a 383-patient population pharmacokinetic study mixing rich and sparse designs.

View Article and Find Full Text PDF
Article Synopsis
  • Drug-target-drug complexes (DTDCs) were observed in patients transitioning from eculizumab to crovalimab for treating paroxysmal nocturnal hemoglobinuria (PNH), due to the different ways these drugs bind to C5.
  • In a phase I/II study, patients experienced transient reductions in crovalimab levels and the formation of DTDCs, with some mild hypersensitivity reactions noted.
  • A mathematical model helped optimize crovalimab dosing, resulting in over a 50% reduction of large DTDCs and improved safety, showing that careful dosing can enhance treatment outcomes for patients using new antibody therapies.
View Article and Find Full Text PDF

Background And Aims: RO7062931 is an N-acetylgalactosamine (GalNAc)-conjugated single-stranded locked nucleic acid oligonucleotide complementary to HBV RNA. GalNAc conjugation targets the liver through the asialoglycoprotein receptor (ASGPR). This two-part phase 1 study evaluated the safety, pharmacokinetics, and pharmacodynamics of RO7062931 in healthy volunteers and patients with chronic hepatitis B (CHB) who were virologically suppressed.

View Article and Find Full Text PDF

Purpose: Arterial stiffness generates vascular alterations that may cause balance disorders and falls. This study aimed to investigate the possible link between arterial stiffness and postural control under different sensorial conditions in patients over 65 years.

Methods: Carotid-femoral pulse wave velocity (PWV) was measured in 47 participants aged over 65 years to evaluate their arterial stiffness (high PWV).

View Article and Find Full Text PDF

Within the challenging context of phase II dose-finding trials, longitudinal analyses may increase drug effect detection power compared to an end-of-treatment analysis. This work proposes cLRT-Mod, a pharmacometric adaptation of the MCP-Mod methodology, which allows the use of nonlinear mixed effect models to first detect a dose-response signal and then identify the doses for the confirmatory phase while accounting for model structure uncertainty. The method was evaluated through extensive clinical trial simulations of a hypothetical phase II dose-finding trial using different scenarios and comparing different methods such as MCP-Mod.

View Article and Find Full Text PDF

In drug development, pharmacometric approaches consist in identifying via a model selection (MS) process the model structure that best describes the data. However, making predictions using a selected model ignores model structure uncertainty, which could impair predictive performance. To overcome this drawback, model averaging (MA) takes into account the uncertainty across a set of candidate models by weighting them as a function of an information criterion.

View Article and Find Full Text PDF

Purpose: This manuscript aims to precisely describe the natural disease progression of Parkinson's disease (PD) patients and evaluate approaches to increase the drug effect detection power.

Methods: An item response theory (IRT) longitudinal model was built to describe the natural disease progression of 423 de novo PD patients followed during 48 months while taking into account the heterogeneous nature of the MDS-UPDRS. Clinical trial simulations were then used to compare drug effect detection power from IRT and sum of item scores based analysis under different analysis endpoints and drug effects.

View Article and Find Full Text PDF

This study aimed to investigate the protective mechanisms or risk factors that can be related to the occurrence of hand climbing-related injuries (CRIH ). CRIH (tendon, pulley, muscle, and joint injuries) were retrospectively screened in 528 adult climbers. The questionnaire contained anthropometric items (e.

View Article and Find Full Text PDF

Objective: In recent years, the Mini-Mental State Examination (MMSE) has been widely used and has been proposed for cognitive decline screening in the framework of a systematic geriatric evaluation in health centers. The aim of the present longitudinal study was to identify the potential determinants of MMSE score and its evolution over a 4-year period in a population aged over sixty years with good general health without dementia and consulting for a health check-up.

Design: Longitudinal study.

View Article and Find Full Text PDF

Background: Correct identification of people at risk for recurrent falls facilitates the establishment of preventive and rehabilitative strategies in older adults.

Objective: The purposes of this study were: (1) to develop and validate a simple clinical scale to stratify risk for recurrent falls in community-dwelling elderly people based on easily obtained social and clinical items and (2) to evaluate the added value of 3 clinical balance tests in predicting this risk.

Design: This was a prospective measurement study.

View Article and Find Full Text PDF

Objective: The aim of the longitudinal study PARTAGE (predictive values of blood pressure and arterial stiffness in institutionalized very aged population) was to determine the predictive value of blood pressure (BP) and arterial stiffness for overall mortality, major cardiovascular events and cognitive decline in a large population of institutionalized patients aged 80 and over. In the study herein, we present the baseline data values of this study.

Methods: A total of 1130 patients were recruited (878 women), living in French and Italian nursing homes.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how various factors like demographics, psychology, and health impact balance and gait decline in elderly individuals, defined by the Tinetti test after two years.!* -
  • It involves 344 participants aged around 63.5 years from Paris, who were assessed twice to identify changes in their balance and gait performance.!* -
  • Results indicate that being female, older age, higher body mass index, osteoarticular pain, and increased anxiety negatively influence balance and gait scores, suggesting targeted prevention strategies are necessary for at-risk individuals.*
View Article and Find Full Text PDF

We assessed the role of clinical and biological parameters on performance in four balance tests in elderly subjects. An observational study was conducted in the Center for Preventive Medicine of Nancy (France) in 2368 community-living elderly subjects aged 60 and older. Body mass index (BMI), Mini-Mental State Examination (MMSE), clock test, "Health score" and use of psychotropic drugs (UPD) were assessed.

View Article and Find Full Text PDF

Background: A poor postural stability in older people is associated with an increased risk of falling. The posturographic tool has widely been used to assess balance control; however, its value in predicting falls remains unclear.

Objective: The purpose of this prospective study was to determine the predictive value of posturography in the estimation of the risk of recurrent falls, including a comparison with standard clinical balance tests, in healthy non-institutionalized persons aged over 65.

View Article and Find Full Text PDF

Aging process is characterized by difficulties in ensuring balance control, especially in conditions of reduced or conflicting sensory information, leading to an increased risk of falling. Conversely, the practise of physical activities (PA) has been recognized as a good approach to improve the quality of balance control. This study aimed to investigate the influence of current and/or past PA on balance-related neurosensorial organization in older adults on the maintenance of the upright stance, especially during sensory conflicting situations.

View Article and Find Full Text PDF